These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 304802)

  • 41. [Gram-positive bacteria as adjuvants (author's transl)].
    Hahn H
    Immun Infekt; 1978 Jun; 6(3):123-6. PubMed ID: 96006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The use of Corynebacterium parvum in pleurodesis].
    Helin T; Haahtela T
    Duodecim; 1988; 104(4):262-5. PubMed ID: 3168834
    [No Abstract]   [Full Text] [Related]  

  • 44. Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes.
    Howard JG; Christie GH; Scott MT
    Cell Immunol; 1973 May; 7(2):290-301. PubMed ID: 4350148
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments.
    Bomford R; Christie GH
    Cell Immunol; 1975 May; 17(1):150-5. PubMed ID: 1079165
    [No Abstract]   [Full Text] [Related]  

  • 46. Chemical and biological properties of a purified lymphoreticular-stimulating fraction of Corynebacterium parvum (Propionibacterium acnes type I).
    Adlam C; Reid DE; Marshall AJ; Torkington P
    J Med Microbiol; 1979 Nov; 12(4):429-40. PubMed ID: 513108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of immunostimulation by Corynebacterium parvum on evolution and metastatic dissemination of Lewis's tumor in mouse C57BL/6 mice].
    Pot-Deprun J; Chouroulinkov I
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):685-8. PubMed ID: 809167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.
    Scott MT
    Cell Immunol; 1972 Nov; 5(3):469-79. PubMed ID: 4405135
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of memory cell-mediated cytotoxic response by systemic administration of Corynebacterium parvum.
    Murahata RI; Zighelboim J
    Cell Immunol; 1979 Feb; 42(2):289-97. PubMed ID: 311692
    [No Abstract]   [Full Text] [Related]  

  • 50. Modulation of suppressor mechanisms in allergic contact dermatitis: 2. Inhibition of suppressor T-lymphocytes by Corynebacterium parvum.
    Knop J; Riechmann R; Macher E
    J Invest Dermatol; 1981 May; 76(5):396-9. PubMed ID: 6453168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria.
    Adlam C; Scott MT
    J Med Microbiol; 1973 Aug; 6(3):261-74. PubMed ID: 4726332
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of Corynebacterium parvum vaccine in conjunction with immunosuppression in renal transplant in dogs.
    Munda R; Alexander JW; Stinnett JD; Weiss MA; Morris MJ
    Transplantation; 1982 Mar; 33(3):333-5. PubMed ID: 7039044
    [No Abstract]   [Full Text] [Related]  

  • 53. [Influence of Corynebacterium parvum, BCG, OK-432 and Lactobacillus casei on the hepatic drug-metabolizing systems and on the oxygen radical production by fixed macrophages in liver of BALB/c mouse].
    Hashimoto S; Yokokura T; Mutai M
    Yakugaku Zasshi; 1984 Apr; 104(4):356-61. PubMed ID: 6491874
    [No Abstract]   [Full Text] [Related]  

  • 54. Induction of interferon production in mouse spleen cell cultures by corynebacterium parvum.
    Hirt HM; Becker H; Kirchner H
    Cell Immunol; 1978 Jun; 38(1):168-75. PubMed ID: 307432
    [No Abstract]   [Full Text] [Related]  

  • 55. Modification of the antitumor action of Corynebacterium parvum by stress.
    Turney TH; Harmsen AG; Jarpe MA
    Physiol Behav; 1986; 37(4):555-8. PubMed ID: 3092254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum.
    Soyka LF; Stephens CC; MacPherson BR; Foster RS
    Int J Immunopharmacol; 1979; 1(2):101-12. PubMed ID: 551956
    [No Abstract]   [Full Text] [Related]  

  • 57. The influence of Propionibacterium acnes (Corynebacterium parvum) fractions on immune response in vivo.
    Mára M; Julák J; Bednár M; Ocenásková J; Miková Z; Dohnalová A
    Zentralbl Bakteriol; 1994 Nov; 281(4):549-55. PubMed ID: 7727904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged fever after pleural instillation of Corynebacterium parvum (Coparvax).
    Laroche CM; Britton M
    Thorax; 1987 Oct; 42(10):823-4. PubMed ID: 3424259
    [No Abstract]   [Full Text] [Related]  

  • 59.
    Palmieri B; Vadalà M
    J Interferon Cytokine Res; 2021 Mar; 41(3):132-136. PubMed ID: 33750214
    [No Abstract]   [Full Text] [Related]  

  • 60. Thymoindependent antigentic stimulation in nude mice: response to polyvinylpyrrolidone and adjuvant effects of Corynebacterium parvum and LH1.
    Créau-Goldberg N; Salomon JC
    Int Arch Allergy Appl Immunol; 1978; 57(1):31-6. PubMed ID: 640744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.